In contrast, an insertion in 17‐β hydroxysteroid dehydrogenase 13 (HSD17B13) rs72613567 T>A appears protective, mitigating progression from steatohepatitis to HCC even among high‐risk PNPLA3 carriers [133]. Here, PNPLA3 is linked to hepatocellular carcinoma.